DK150517C - Analogifremgangsmaade til fremstilling af 2,5-dihydro-1,2-thiazino(5,6-b)indol-3-carboxamid-1,1-dioxider eller fysiologisk acceptable salte deraf - Google Patents

Analogifremgangsmaade til fremstilling af 2,5-dihydro-1,2-thiazino(5,6-b)indol-3-carboxamid-1,1-dioxider eller fysiologisk acceptable salte deraf

Info

Publication number
DK150517C
DK150517C DK048478A DK48478A DK150517C DK 150517 C DK150517 C DK 150517C DK 048478 A DK048478 A DK 048478A DK 48478 A DK48478 A DK 48478A DK 150517 C DK150517 C DK 150517C
Authority
DK
Denmark
Prior art keywords
physially
thiazino
dioxides
indol
carboxamide
Prior art date
Application number
DK048478A
Other languages
Danish (da)
English (en)
Other versions
DK150517B (da
DK48478A (da
Inventor
Guenter Trummlitz
Wolfhard Engel
Ernst Seeger
Walter Haarmann
Guenther Engelhardt
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of DK48478A publication Critical patent/DK48478A/da
Publication of DK150517B publication Critical patent/DK150517B/da
Application granted granted Critical
Publication of DK150517C publication Critical patent/DK150517C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK048478A 1977-02-03 1978-02-02 Analogifremgangsmaade til fremstilling af 2,5-dihydro-1,2-thiazino(5,6-b)indol-3-carboxamid-1,1-dioxider eller fysiologisk acceptable salte deraf DK150517C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2704485 1977-02-03
DE19772704485 DE2704485A1 (de) 1977-02-03 1977-02-03 Neue 2,5-dihydro-1,2-thiazino eckige klammer auf 5,6-b eckige klammer zu indol-3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Publications (3)

Publication Number Publication Date
DK48478A DK48478A (da) 1978-08-04
DK150517B DK150517B (da) 1987-03-16
DK150517C true DK150517C (da) 1987-10-19

Family

ID=6000267

Family Applications (1)

Application Number Title Priority Date Filing Date
DK048478A DK150517C (da) 1977-02-03 1978-02-02 Analogifremgangsmaade til fremstilling af 2,5-dihydro-1,2-thiazino(5,6-b)indol-3-carboxamid-1,1-dioxider eller fysiologisk acceptable salte deraf

Country Status (35)

Country Link
US (1) US4137313A (zh)
JP (1) JPS5398998A (zh)
AT (3) AT355585B (zh)
AU (1) AU516178B2 (zh)
BE (1) BE863588A (zh)
BG (1) BG36499A3 (zh)
CA (1) CA1088064A (zh)
CH (1) CH639389A5 (zh)
CS (1) CS194195B2 (zh)
DD (1) DD134767A5 (zh)
DE (1) DE2704485A1 (zh)
DK (1) DK150517C (zh)
ES (5) ES466555A1 (zh)
FI (1) FI62097C (zh)
FR (1) FR2379542A1 (zh)
GB (1) GB1569238A (zh)
GR (1) GR64418B (zh)
HK (1) HK71383A (zh)
HU (1) HU175550B (zh)
IE (1) IE46185B1 (zh)
IL (1) IL53948A (zh)
IT (1) IT1105151B (zh)
LU (1) LU78974A1 (zh)
MY (1) MY8400283A (zh)
NL (1) NL7801183A (zh)
NO (1) NO148490C (zh)
NZ (1) NZ186374A (zh)
PH (1) PH13882A (zh)
PL (1) PL109705B1 (zh)
PT (1) PT67607B (zh)
SE (1) SE436749B (zh)
SG (1) SG48083G (zh)
SU (1) SU654173A3 (zh)
YU (1) YU24478A (zh)
ZA (1) ZA78630B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2838377A1 (de) * 1978-09-02 1980-03-20 Thomae Gmbh Dr K Neue 4-hydroxy-2h eckige klammer auf 1 eckige klammer zu benzothieno eckige klammer auf 2,3-e eckige klammer zu -1,2- thiazin-3-carboxamid-1,1-dioxide sowie deren salze, deren verwendung und verfahren zu ihrer herstellung
AU5811280A (en) 1979-06-13 1980-12-18 F. Hoffmann-La Roche Ag Thiazine derivatives
GR80576B (en) * 1983-10-17 1984-11-29 Fujisawa Pharmaceutical Co Thiazine derivatives, process for preparation thereof and pharmaceutical composition comprising the same
US4683306A (en) * 1984-07-13 1987-07-28 Yuhan Corporation Co., Ltd. Process for the preparation of 3,4-dihydro-2-substituted-2H-1,2-thiazine-carboxylic acid 1,1-dioxide derivatives
US6407124B1 (en) 1998-06-18 2002-06-18 Bristol-Myers Squibb Company Carbon substituted aminothiazole inhibitors of cyclin dependent kinases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH588693A5 (zh) * 1973-12-10 1977-06-15 Image Analysing Computers Ltd
IL47877A (en) * 1974-08-26 1978-10-31 Sparamedica Ag Thienothiazine carboxamide derivatives,their manufacture and pharmaceutical compositions containing them
AT345847B (de) * 1974-11-08 1978-10-10 Thomae Gmbh Dr K Verfahren zur herstellung neuer 4-hydroxy-2h- naphtho- (2,1-e)-1,2-thiazin-3-carboxamid-1,1-dioxid und deren salze

Also Published As

Publication number Publication date
ES469111A1 (es) 1978-11-16
PL204401A1 (pl) 1979-04-09
DD134767A5 (de) 1979-03-21
NO148490B (no) 1983-07-11
AU516178B2 (en) 1981-05-21
SE436749B (sv) 1985-01-21
JPS5398998A (en) 1978-08-29
DK150517B (da) 1987-03-16
IE780246L (en) 1978-08-03
FR2379542A1 (fr) 1978-09-01
MY8400283A (en) 1984-12-31
HK71383A (en) 1983-12-30
US4137313A (en) 1979-01-30
DE2704485A1 (de) 1978-08-10
IL53948A (en) 1980-10-26
ES469112A1 (es) 1978-11-16
NO780370L (no) 1978-08-04
PH13882A (en) 1980-10-27
SE7714833L (sv) 1978-08-04
AU3293178A (en) 1979-08-09
PT67607B (de) 1980-03-03
PT67607A (de) 1978-03-01
ES466555A1 (es) 1978-10-01
YU24478A (en) 1982-10-31
GB1569238A (en) 1980-06-11
CS194195B2 (en) 1979-11-30
NL7801183A (nl) 1978-08-07
GR64418B (en) 1980-03-21
AT355590B (de) 1980-03-10
CH639389A5 (de) 1983-11-15
JPS6111235B2 (zh) 1986-04-01
HU175550B (hu) 1980-08-28
IT7847828A0 (it) 1978-01-27
NO148490C (no) 1983-10-19
ATA269679A (de) 1979-08-15
AT355585B (de) 1980-03-10
IL53948A0 (en) 1978-04-30
SU654173A3 (ru) 1979-03-25
FI62097C (fi) 1982-11-10
NZ186374A (en) 1980-03-05
SG48083G (en) 1984-07-27
BG36499A3 (en) 1984-11-15
LU78974A1 (de) 1979-05-25
IT1105151B (it) 1985-10-28
ZA78630B (en) 1979-10-31
DK48478A (da) 1978-08-04
ATA269579A (de) 1979-08-15
BE863588A (fr) 1978-08-02
FI780324A (fi) 1978-08-04
PL109705B1 (en) 1980-06-30
FI62097B (fi) 1982-07-30
ES469110A1 (es) 1978-11-16
CA1088064A (en) 1980-10-21
AT355591B (de) 1980-03-10
ES469113A1 (es) 1978-11-16
FR2379542B1 (zh) 1982-12-03
IE46185B1 (en) 1983-03-23
ATA11178A (de) 1979-08-15

Similar Documents

Publication Publication Date Title
DK152753C (da) Analogifremgangsmaade til fremstilling af 2-hydroxymethyl-3,4,5-trihydroxypiperidinderivater eller farmaceutisk acceptable salte eller stereoisomere deraf
DK149344C (da) Analogifremgangsmaade til fremstilling af 4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxider
DK149449C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater eller farmaceutisk acceptable salte deraf
DK163244C (da) Analogifremgangsmaade til fremstilling af 7-oe2-(2-aminothiazol-4-yl)-2-oxyimino-acetamidoaa-ceph-3-em-4-carboxylsyrederivater eller fysiologisk acceptable salte deraf
DK148260C (da) Analogifremgangsmaade til fremstilling af 1,3,8-trisubstituerede xantinderivater eller salte deraf
DK152114C (da) Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf
DK258078A (da) Fremgangsmaade til fremstilling af 7alfa-methoxy-7beta-(1,3-dithiethan-2-carboxamido) cephalosporansyre-derivater
DK146160C (da) Analogifremgangsmaade til fremstilling af n-(5-tetrazolyl)-4-oxo-4h-pyrimido(2,1-b)benzothiazol-3-carboxamider eller farmaceutisk acceptable salte deraf med baser
DK155670C (da) Analogifremgangsmaade til fremstilling af sesquiterpenderivater eller farmaceutisk acceptable salte deraf
DK27078A (da) Fremgangsmaade til fremstilling af imidazoquinoliner eller salte deraf
DK151805C (da) Analogifremgangsmaade til fremstilling af 20,21-di-nor-eburnameninderivater eller farmaceutisk acceptable additionssalte deraf
DK324979A (da) Fremgangsmaade til fremstilling af imidazoquinoxaliner eller salte deraf
DK145263C (da) Analogifremgangsmaade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK511878A (da) Fremgangsmaade til fremstilling af imidazobenzoazepiner eller salte deraf
DK165005C (da) Analogifremgangsmaade til fremstilling af 4,5-dihydro-4-oxofuran-2-carboxylsyrederivater eller terapeutisk acceptable salte deraf
DK157081C (da) Analogifremgangsmaade til fremstilling af 3-oe(s)-1'-phenylethylaminoaapropylaminobleomycin eller ugiftige salte deraf
DK158227C (da) Analogifremgangsmaade til fremstilling af substituerede imidazooe1,5-aaapyridiner eller 5,6,7,8-tetrahydroderivater deraf eller salte deraf
DK150517C (da) Analogifremgangsmaade til fremstilling af 2,5-dihydro-1,2-thiazino(5,6-b)indol-3-carboxamid-1,1-dioxider eller fysiologisk acceptable salte deraf
DK157021C (da) Analogifremgangsmaade til fremstilling af 2,3-polymethylen-4-oxo-4h-pyrido- eller -azepinooe1,2-aaapyrimidiner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf
DK150521C (da) Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk acceptable salte deraf
DK307378A (da) Fremgangsmaade til fremstilling af 1,2,4-oxadiazoler
DK147198C (da) Analogifremgangsmaade til fremstilling af 9-hydroxyethoxymethylguanin-monophosphat eller salte deraf
DK147918C (da) Analogifremgangsmaade til fremstilling af thymosin alfa1 (18 - 28) eller farmaceutisk acceptable salte deraf
DK143403C (da) Analogifremgangsmaade til fremstilling af 8-(1h-tetrazol-5-yl)-11h-pyrido(2,1-b)quinazolin-11-oner eller salte deraf
DK153843C (da) Analogifremgangsmaade til fremstilling af 5-substituerede 10,11-dihydro-5h-dibenzooea,daacyclohepten-5,10-iminer eller salte deraf

Legal Events

Date Code Title Description
PBP Patent lapsed